多发性硬化再髓鞘化病灶的新型晚期MRI生物标志物
研究纳入115例多发性硬化患者和76名健康对照,用3T MRI的定量磁化率图(QSM)、髓鞘水分数(MWF)和神经突密度指数(NDI)将白质病灶分为5类QSM类型;纵向随访40例患者2年,并用3例患者脑组织63个白质病灶做死后组织病理-QSM验证。结果显示低信号/等信号病灶MWF和NDI较高,2年随访MWF增加;QSM识别完全再髓鞘化区敏感度88.89%、特异度100%。
要点
- QSM将多发性硬化白质病灶分为等信号、低信号、高信号、低信号环和顺磁环病灶(PRLs)5类。
- 低信号/等信号病灶平均MWF和NDI高于其他QSM类型(p<0.0001),2年随访MWF增加。
- 死后验证QSM识别完全再髓鞘化区敏感度88.89%、特异度100%,识别慢性活动/闷烧病灶为PRLs敏感度92.86%、特异度86.36%。
核心结论
- 结果首次提供证据表明可在临床环境中区分多发性硬化慢性病灶,为开发和评估再髓鞘化治疗提供新生物标志物。
研究设计与样本
- 研究一为前瞻性队列横断面研究,纳入115例多发性硬化患者和76名健康对照,行3T MRI采集QSM、MWF和NDI图。
- 研究二为纵向研究,纳入40例多发性硬化患者,随访2年观察病灶演变。
- 研究三为死后组织病理-QSM验证研究,纳入3例多发性硬化患者脑组织,评估63个白质病灶的QSM分类准确性。
主要发现
- 基线时低信号和等信号病灶的平均MWF和NDI值高于其他QSM病灶类型(p<0.0001)。
- 2年随访时低信号/等信号病灶的MWF增加。
- 死后分析显示QSM识别完全再髓鞘化区为低信号/等信号,敏感度88.89%、特异度100%。
- QSM识别慢性非活动病灶为高信号,敏感度71.43%、特异度92.00%。
- QSM识别慢性活动/闷烧病灶为PRLs,敏感度92.86%、特异度86.36%。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Neuropathological studies have shown that multiple sclerosis (MS) lesions are heterogeneous in terms of myelin/axon damage and repair as well as iron content. However, it remains a challenge to identify specific chronic lesion types, especially remyelinated lesions, in vivo in patients with MS. METHODS: We performed 3 studies: (1) a cross-sectional study in a prospective cohort of 115 patients with MS and 76 healthy controls, who underwent 3 T magnetic resonance imaging (MRI) for quantitative susceptibility mapping (QSM), myelin water fraction (MWF), and neurite density index (NDI) maps. White matter (WM) lesions in QSM were classified into 5 QSM lesion types (iso-intense, hypo-intense, hyperintense, lesions with hypo-intense rims, and lesions with paramagnetic rim legions [PRLs]); (2) a longitudinal study of 40 patients with MS to study the evolution of lesions over 2 years; (3) a postmortem histopathology-QSM validation study in 3 brains of patients with MS to assess the accuracy of QSM classification to identify neuropathological lesion types in 63 WM lesions. RESULTS: At baseline, hypo- and isointense lesions showed higher mean MWF and NDI values compared to other QSM lesion types (p < 0.0001). Further, at 2-year follow-up, hypo-/iso-intense lesions showed an increase in MWF. Postmortem analyses revealed that QSM highly accurately identifies (1) fully remyelinated areas as hypo-/iso-intense (sensitivity = 88.89% and specificity = 100%), (2) chronic inactive lesions as hyperintense (sensitivity = 71.43% and specificity = 92.00%), and (3) chronic active/smoldering lesions as PRLs (sensitivity = 92.86% and specificity = 86.36%). INTERPRETATION: These results provide the first evidence that it is possible to distinguish chronic MS lesions in a clinical setting, hereby supporting with new biomarkers to develop and assess remyelinating treatments. ANN NEUROL 2022;92:486-502.
引用
- Rahmanzadeh R, Galbusera R, Lu PJ, et al. A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis. Ann Neurol. 2022. PMID: 35713309. doi:10.1002/ana.26441
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。